Joint Action25 Okt 2020

Osteoarthritis Economics 101 with Elena Losina

The economic burden due to osteoarthritis (OA) is massive and is the result of direct costs to the health care system, indirect costs to individuals living with OA, and the intangible costs of living with a chronic disabling condition. Compared to age and sex-matched peers, OA patients incur higher out of pocket health-related expenditures. People with OA also incur substantial costs due to lost productivity, including both absenteeism (days off work) and presenteeism (reduced self-reported productivity at work). As the burden of OA rises globally, so too will the economic burden

On this episode we discuss: the basic principles of osteoarthritis economics, average direct healthcare costs of living with osteoarthritis, total healthcare costs to the economy and much more.

Professor Elena Losina, Robert W. Lovett Professor of Orthopedic Surgery (Biostatistics) at Harvard Medical School, is an internationally recognized investigator in the epidemiology and outcomes of musculoskeletal disorders. She is a Director of the Policy and Innovation eValuation in Orthopedic Treatments (PIVOT) Center and co-Director of the Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) and is a Principal Investigator of the Methodology Core of the Robert Brigham Multidisciplinary Clinical Research Center at Brigham and Women’s Hospital, Boston, MA. Dr. Losina has published over 300 peer-reviewed articles. Dr. Losina leads an NIH funded multi-sited project to conduct health policy evaluations related to surgical and non-surgical management of knee osteoarthritis. She is recognized internationally for her expertise in melding rigorous clinical research methodologies across multiple clinical disciplines, from orthopedics and osteoarthritis to global health.

RESOURCES

CONNECT WITH US

Twitter: @ProfDavidHunter @jointactionorg
Email: hello@jointaction.info
Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(175)

Your osteoarthritis listener questions with Vicky and David

Have you ever wondered whether your painful, stiff joints are just something you have to put up with, or whether there is actually something that can be done? On this week's episode of Joint Action, V...

19 Juli 28min

Choosing shoes for osteoarthritis with A/Prof Kade Paterson

Could the shoes you wear every day be making your knee osteoarthritis better or worse? On this week's episode of Joint Action, Kade Paterson joins Professor David Hunter to explain why footwear matter...

5 Juli 33min

Science without borders: a call to the osteoarthritis community

What happens to global science when funding is cut, borders close, and collaboration is threatened? In this special episode of Joint Action, Professor David Hunter reflects on the proposed changes to ...

21 Juni 17min

When we say “the evidence shows this works,” who was actually included in that evidence? with Prof Christian Barton

When we say a treatment works for knee osteoarthritis, it is worth asking: works for whom? On this week's episode of Joint Action, Professor Christian Barton unpacks the blind spots in osteoarthritis ...

7 Juni 30min

Your osteoarthritis listener questions with David and Vicky

This week on Joint Action, Vicky turns the tables and puts the questions to Professor David Hunter. Three listeners submitted questions spanning gut health, total knee replacement, and the frustrating...

24 Maj 22min

Do you really need surgery for your knee osteoarthritis? with Dr Howard Luks (2021)

The number of surgical procedures for musculoskeletal diseases such as osteoarthritis has increased exponentially over the past years, some of which are unnecessary and leave patients no better off th...

10 Maj 41min

Finding Responders: The Next Phase of OA Biomarkers with Dr Virginia Kraus, Dr Peter Mesenbrink, and Dr Jamie Collins

Can identifying the right patients and the right endpoints transform how we test new osteoarthritis treatments? On this week's episode of Joint Action, we unpack what the FNIH Biomarkers Consortium ha...

26 Apr 29min

Defining the early-stage OA patient: the EsSKOA initiative with Dr Armaghan Mahmoudian

What does it actually mean to have 'early-stage' osteoarthritis, and does catching it sooner really make a difference? On this week's episode of Joint Action, learn more about early-stage knee osteoar...

12 Apr 38min